dr. brufsky on the disease-free survival of aromatase inhibitors for breast cancer
Published 7 years ago • 471 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
0:30
dr. brufsky on adjuvant bisphosphonates for patients with breast cancer
-
1:06
dr. brufsky on challenges in breast cancer
-
2:10
dr. brufsky on anastrozole versus tamoxifen in dcis
-
1:29
dr. brufsky on the colet trial for triple-negative breast cancer
-
1:49
dr. brufsky on multiparametric genomic assays in breast cancer
-
1:46
dr. brufsky discusses adjuvant bisphosphonates as a new standard of care
-
1:16
dr. brufsky advises doctors on bevacizumab for breast cancer
-
1:56
dr. melisko on duration of aromatase inhibitor use in breast cancer
-
1:30
dr. brufsky on genomic assays for breast cancer
-
1:15
dr. brufsky on reducing the cost of care in breast oncology
-
1:01
dr. brufsky on trastuzumab biosimilars in breast cancer
-
1:07
dr. brufsky on challenges facing biosimilars in breast cancer
-
1:38
dr. brufsky on the results of a study of trastuzumab and eribulin for her2 mbc
-
6:12
extended aromatase inhibitor risk/benefit
-
1:41
dr. brufsky on implementing pertuzumab in her2 breast cancer
-
2:27
dr. judy garber and aromatase inhibitors for breast cancer prevention | dana-farber cancer institute
-
2:01
dr. gralow on the use of bisphosphonates in early-stage breast cancer
-
0:57
dr. brufsky on biosimilars being explored in oncology
-
5:42
improvements in breast cancer treatment - dr. adam brufsky asco 2014